TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Clinical Study on the Effect of Home-based Treatment of Patients With COPD. Improved Cooperation Between Hospital and Primary Healthcare System.
Brief Summary: We want to improve the treatment of patients suffering from COPD (3-4) by early medical intervention in the patients home. A close cooperation between the hospital and the primary healthcare system will hopefully reduce hospitalisation, drug consumption and improve quality of life. Following up from the hospital and the primary healthcare in cooperation may lead to earlier detection and treatment of exacerbations in COPD.

The main outcome variable will be number of hospitalizations assessed simply by counting. The second objective will be Quality of life and activation assessed by different questionnaires included in St.George´s Respiratory Questionnaire.


Options:
A: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Arm Label: Community Paramedicine; Type: EXPERIMENTAL; Interventions: Other: Community Paramedicine | Intervention Type: OTHER; Name: Community Paramedicine; Assigned to Arm(s): Community Paramedicine | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care
B: N/A
C: Arm Label: usual care; Type: OTHER; Interventions: Behavioral: usual care | Arm Label: cooperation; Type: EXPERIMENTAL; Interventions: Behavioral: closer collaboration between hospital and primary healthcare system | Intervention Type: BEHAVIORAL; Name: closer collaboration between hospital and primary healthcare system; Assigned to Arm(s): cooperation | Intervention Type: BEHAVIORAL; Name: usual care; Assigned to Arm(s): usual care
D: Arm Label: comprehensive care programme; Type: ACTIVE_COMPARATOR; Interventions: Other: Comprehensive care programme | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Comprehensive care programme; Assigned to Arm(s): comprehensive care programme

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Clinical Study on the Effect of Home-based Treatment of Patients With COPD. Improved Cooperation Between Hospital and Primary Healthcare System.
Brief Summary: We want to improve the treatment of patients suffering from COPD (3-4) by early medical intervention in the patients home. A close cooperation between the hospital and the primary healthcare system will hopefully reduce hospitalisation, drug consumption and improve quality of life. Following up from the hospital and the primary healthcare in cooperation may lead to earlier detection and treatment of exacerbations in COPD.

The main outcome variable will be number of hospitalizations assessed simply by counting. The second objective will be Quality of life and activation assessed by different questionnaires included in St.George´s Respiratory Questionnaire.


Options:
A: Arm Label: Inpatient hospitalization; Type: ACTIVE_COMPARATOR; Interventions: Other: Inpatient Hospitalization | Arm Label: Home hospitalization; Type: EXPERIMENTAL; Interventions: Other: Home hospitalization | Intervention Type: OTHER; Name: Home hospitalization; Assigned to Arm(s): Home hospitalization | Intervention Type: OTHER; Name: Inpatient Hospitalization; Assigned to Arm(s): Inpatient hospitalization
B: Arm Label: usual care; Type: OTHER; Interventions: Behavioral: usual care | Arm Label: cooperation; Type: EXPERIMENTAL; Interventions: Behavioral: closer collaboration between hospital and primary healthcare system | Intervention Type: BEHAVIORAL; Name: closer collaboration between hospital and primary healthcare system; Assigned to Arm(s): cooperation | Intervention Type: BEHAVIORAL; Name: usual care; Assigned to Arm(s): usual care
C: Arm Label: Remote-Monitoring Program; Type: EXPERIMENTAL; Interventions: Device: Cloud Dx Kit with remote-monitoring | Arm Label: Self-Monitoring Program; Type: EXPERIMENTAL; Interventions: Device: Cloud Dx Kit with self-monitoring | Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Cloud Dx Kit with self-monitoring; Assigned to Arm(s): Self-Monitoring Program | Intervention Type: DEVICE; Name: Cloud Dx Kit with remote-monitoring; Assigned to Arm(s): Remote-Monitoring Program
D: Arm Label: telemedicine; Type: EXPERIMENTAL; Interventions: Other: Telemedical admission and treatment in the patients´ own homes instead of conventional admission and treatment at the hospital | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Telemedical admission and treatment in the patients´ own homes instead of conventional admission and treatment at the hospital; Assigned to Arm(s): telemedicine

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Clinical Study on the Effect of Home-based Treatment of Patients With COPD. Improved Cooperation Between Hospital and Primary Healthcare System.
Brief Summary: We want to improve the treatment of patients suffering from COPD (3-4) by early medical intervention in the patients home. A close cooperation between the hospital and the primary healthcare system will hopefully reduce hospitalisation, drug consumption and improve quality of life. Following up from the hospital and the primary healthcare in cooperation may lead to earlier detection and treatment of exacerbations in COPD.

The main outcome variable will be number of hospitalizations assessed simply by counting. The second objective will be Quality of life and activation assessed by different questionnaires included in St.George´s Respiratory Questionnaire.


Options:
A: Arm Label: Best available care (BAC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Best available care (BAC) | Arm Label: Telerehabilitation (TH); Type: EXPERIMENTAL; Interventions: Behavioral: Telerehabilitation (TH) | Intervention Type: BEHAVIORAL; Name: Best available care (BAC); Assigned to Arm(s): Best available care (BAC) | Intervention Type: BEHAVIORAL; Name: Telerehabilitation (TH); Assigned to Arm(s): Telerehabilitation (TH)
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Tele rehab | Intervention Type: BEHAVIORAL; Name: Tele rehab; Assigned to Arm(s): Intervention group
C: Arm Label: KOLwebben; Type: EXPERIMENTAL; Interventions: Behavioral: KOLwebben | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: KOLwebben; Assigned to Arm(s): KOLwebben
D: Arm Label: usual care; Type: OTHER; Interventions: Behavioral: usual care | Arm Label: cooperation; Type: EXPERIMENTAL; Interventions: Behavioral: closer collaboration between hospital and primary healthcare system | Intervention Type: BEHAVIORAL; Name: closer collaboration between hospital and primary healthcare system; Assigned to Arm(s): cooperation | Intervention Type: BEHAVIORAL; Name: usual care; Assigned to Arm(s): usual care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cardioselective Beta-Blockade Using Bisoprolol in Patients With Chronic Heart Failure (CHF) and Coexistent Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) With or Without Significant Reversibility.
Brief Summary: The principal research objectives are to demonstrate cardioselective beta-blockade using bisoprolol is not inferior to placebo with regard to pulmonary function and improves quality of life in patients with heart failure and coexistent moderate or severe chronic obstructive pulmonary disease with or without significant reversibility. Patients will be followed up for 4 months during which bisoprolol will be up-titrated to the maximum clinically tolerated dose. Health status will be assessed using a generic and two disease specific questionnaires, and pulmonary function by spirometry, body box plethysmography, and cardiopulmonary exercise testing.


Options:
A: Arm Label: iVAPS with AutoEPAP; Type: EXPERIMENTAL; Interventions: Device: Astral | Arm Label: iVAPS with manual EPAP; Type: ACTIVE_COMPARATOR; Interventions: Device: Astral | Intervention Type: DEVICE; Name: Astral; Assigned to Arm(s): iVAPS with AutoEPAP, iVAPS with manual EPAP
B: Arm Label: Low Comorbidity Index Score; Type: OTHER; Interventions: Other: Exercise | Arm Label: High Comorbidity Index Score; Type: OTHER; Interventions: Other: Exercise | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): High Comorbidity Index Score, Low Comorbidity Index Score
C: Arm Label: Oxygen; Type: EXPERIMENTAL; Interventions: Drug: Oxygen | Arm Label: No oxygen; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Oxygen
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Bisoprolol | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Bisoprolol; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-method Study of a Low-salt Dietary Approach to Control Blood Pressure in the Bangladeshi Chronic Kidney Disease Population.
Brief Summary: The aim of this study is to assess the benefits of using low-salt and healthy eating educational programme, designed specifically for Bangladeshi kidney patients, compared to the usual diet advice given by the clinic dietitians.


Options:
A: Arm Label: Study group; Type: EXPERIMENTAL; Interventions: Behavioral: Low-salt educational programme, Behavioral: Low-salt Bangladeshi educational programme | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Low-salt educational programme; Assigned to Arm(s): Study group | Intervention Type: BEHAVIORAL; Name: Low-salt Bangladeshi educational programme; Assigned to Arm(s): Study group | Intervention Type: BEHAVIORAL; Name: Low-salt Bangladeshi educational programme; Assigned to Arm(s): Study group
B: Arm Label: SCT-based behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SCT-based behavioral intervention | Arm Label: Attention control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control | Intervention Type: BEHAVIORAL; Name: SCT-based behavioral intervention; Assigned to Arm(s): SCT-based behavioral intervention | Intervention Type: BEHAVIORAL; Name: Attention Control; Assigned to Arm(s): Attention control
C: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Other: Dietary sodium restriction | Arm Label: Group B; Type: EXPERIMENTAL; Interventions: Other: Dialysate sodium concentration reduction | Arm Label: Group C; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Dietary sodium restriction; Assigned to Arm(s): Group A | Intervention Type: OTHER; Name: Dialysate sodium concentration reduction; Assigned to Arm(s): Group B
D: Arm Label: Low Sodium Diet; Type: EXPERIMENTAL; Interventions: Behavioral: Low Sodium Diet | Arm Label: Usual Diet; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Low Sodium Diet; Assigned to Arm(s): Low Sodium Diet

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-method Study of a Low-salt Dietary Approach to Control Blood Pressure in the Bangladeshi Chronic Kidney Disease Population.
Brief Summary: The aim of this study is to assess the benefits of using low-salt and healthy eating educational programme, designed specifically for Bangladeshi kidney patients, compared to the usual diet advice given by the clinic dietitians.


Options:
A: Arm Label: Intervention SUBLIME; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention SUBLIME | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intervention SUBLIME; Assigned to Arm(s): Intervention SUBLIME
B: Arm Label: Intensive education of low salt diet; Type: EXPERIMENTAL; Interventions: Behavioral: Intensive education of low salt diet | Arm Label: Conventional diet group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intensive education of low salt diet; Assigned to Arm(s): Intensive education of low salt diet
C: Arm Label: Study group; Type: EXPERIMENTAL; Interventions: Behavioral: Low-salt educational programme, Behavioral: Low-salt Bangladeshi educational programme | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Low-salt educational programme; Assigned to Arm(s): Study group | Intervention Type: BEHAVIORAL; Name: Low-salt Bangladeshi educational programme; Assigned to Arm(s): Study group | Intervention Type: BEHAVIORAL; Name: Low-salt Bangladeshi educational programme; Assigned to Arm(s): Study group
D: Arm Label: Usual Care (UC); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Social Cognitive Theory (SCT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Social Cognitive Theory | Arm Label: Monitoring; Type: ACTIVE_COMPARATOR; Interventions: Other: Monitoring | Arm Label: Combined; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Social Cognitive Theory, Other: Monitoring | Intervention Type: BEHAVIORAL; Name: Social Cognitive Theory; Assigned to Arm(s): Combined, Social Cognitive Theory (SCT) | Intervention Type: OTHER; Name: Monitoring; Assigned to Arm(s): Combined, Monitoring

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia
Brief Summary: The purpose of this study is to refine and evaluate the Preventing Recurrence of Thromboembolic Events through Coordinated Treatment in the District of Columbia (PROTECT DC) intervention. PROTECT DC is a program consisting of in-hospital education coupled with community-based "stroke navigators" and is designed to reduce the rate of vascular events or death in a population of underserved individuals with stroke.


Options:
A: Arm Label: Navigation Group; Type: EXPERIMENTAL; Interventions: Behavioral: PROTECT DC | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: PROTECT DC; Assigned to Arm(s): Navigation Group
B: Arm Label: Standard care (SC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Arm Label: Interventional care (IC); Type: EXPERIMENTAL; Interventions: Behavioral: CAPSYS | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard care (SC) | Intervention Type: BEHAVIORAL; Name: CAPSYS; Assigned to Arm(s): Interventional care (IC)
C: Arm Label: Peer-Led Stroke Recurrence Prevention Education; Type: EXPERIMENTAL; Interventions: Behavioral: Prevent Return of Stroke | Arm Label: Usual Care (Delayed Intervention); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Prevent Return of Stroke | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Peer-Led Stroke Recurrence Prevention Education | Intervention Type: BEHAVIORAL; Name: Prevent Return of Stroke; Assigned to Arm(s): Usual Care (Delayed Intervention)
D: Arm Label: DESERVE education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DESERVE education | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: DESERVE education; Assigned to Arm(s): DESERVE education

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of Columbia
Brief Summary: The purpose of this study is to refine and evaluate the Preventing Recurrence of Thromboembolic Events through Coordinated Treatment in the District of Columbia (PROTECT DC) intervention. PROTECT DC is a program consisting of in-hospital education coupled with community-based "stroke navigators" and is designed to reduce the rate of vascular events or death in a population of underserved individuals with stroke.


Options:
A: Arm Label: PREVENT program; Type: EXPERIMENTAL; Interventions: Behavioral: PREVENT program | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: PREVENT program; Assigned to Arm(s): PREVENT program | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care
B: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: Instruction in physical training program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Instruction in physical training program; Assigned to Arm(s): Intervention arm
C: Arm Label: Navigation Group; Type: EXPERIMENTAL; Interventions: Behavioral: PROTECT DC | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: PROTECT DC; Assigned to Arm(s): Navigation Group
D: Arm Label: 1: Care management; Type: EXPERIMENTAL; Interventions: Behavioral: Care Management | Arm Label: 2: Written Materials; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Written Materials | Intervention Type: BEHAVIORAL; Name: Care Management; Assigned to Arm(s): 1: Care management | Intervention Type: BEHAVIORAL; Name: Written Materials; Assigned to Arm(s): 2: Written Materials

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: a Phase 2 Study in the Old World
Brief Summary: This study is to determine the effectiveness and safety of WR 279,396, a topical cream for the treatment of cutaneous leishmaniasis. This study is to be conducted with a placebo control under double-blind conditions in a local population group in Tunisia where leishmaniasis is endemic.


Options:
A: Arm Label: WR 279,396 Topical Treament; Type: EXPERIMENTAL; Interventions: Drug: WR 279,396 topical cream | Arm Label: Paromomycin Alone Topical treatment; Type: EXPERIMENTAL; Interventions: Drug: Paromomycin Alone topical cream | Arm Label: Vehicle Placebo Cream; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle placebo cream | Intervention Type: DRUG; Name: WR 279,396 topical cream; Assigned to Arm(s): WR 279,396 Topical Treament | Intervention Type: DRUG; Name: Paromomycin Alone topical cream; Assigned to Arm(s): Paromomycin Alone Topical treatment | Intervention Type: DRUG; Name: Vehicle placebo cream; Assigned to Arm(s): Vehicle Placebo Cream
B: Arm Label: WR 279,396; Type: EXPERIMENTAL; Interventions: Drug: WR 279,396 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: WR 279,396; Assigned to Arm(s): WR 279,396 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: IL SSG; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sodium Stibogluconate | Arm Label: ETC+MWT; Type: EXPERIMENTAL; Interventions: Procedure: Electro-thermo-coagulation, Drug: DAC N-055 | Arm Label: MWT; Type: EXPERIMENTAL; Interventions: Drug: DAC N-055 | Intervention Type: PROCEDURE; Name: Electro-thermo-coagulation; Assigned to Arm(s): ETC+MWT | Intervention Type: DRUG; Name: Sodium Stibogluconate; Assigned to Arm(s): IL SSG | Intervention Type: DRUG; Name: DAC N-055; Assigned to Arm(s): ETC+MWT, MWT
D: Arm Label: Sodium stibogluconate intravenous; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sodium stibogluconate (Pentostam) | Arm Label: ThermoMed device; Type: EXPERIMENTAL; Interventions: Device: ThermoMed | Intervention Type: DRUG; Name: Sodium stibogluconate (Pentostam); Assigned to Arm(s): Sodium stibogluconate intravenous | Intervention Type: DEVICE; Name: ThermoMed; Assigned to Arm(s): ThermoMed device

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: a Phase 2 Study in the Old World
Brief Summary: This study is to determine the effectiveness and safety of WR 279,396, a topical cream for the treatment of cutaneous leishmaniasis. This study is to be conducted with a placebo control under double-blind conditions in a local population group in Tunisia where leishmaniasis is endemic.


Options:
A: Arm Label: WR 279,396; Type: EXPERIMENTAL; Interventions: Drug: WR 279,396 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: WR 279,396; Assigned to Arm(s): WR 279,396 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: WR 279,396 Topical Treament; Type: EXPERIMENTAL; Interventions: Drug: WR 279,396 topical cream | Arm Label: Paromomycin Alone Topical treatment; Type: EXPERIMENTAL; Interventions: Drug: Paromomycin Alone topical cream | Arm Label: Vehicle Placebo Cream; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vehicle placebo cream | Intervention Type: DRUG; Name: WR 279,396 topical cream; Assigned to Arm(s): WR 279,396 Topical Treament | Intervention Type: DRUG; Name: Paromomycin Alone topical cream; Assigned to Arm(s): Paromomycin Alone Topical treatment | Intervention Type: DRUG; Name: Vehicle placebo cream; Assigned to Arm(s): Vehicle Placebo Cream
C: Arm Label: ETC + DAC N-055; Type: EXPERIMENTAL; Interventions: Other: Electro-thermo-coagulation, Drug: DAC N-055 | Arm Label: ETC + physiological saline; Type: ACTIVE_COMPARATOR; Interventions: Other: Electro-thermo-coagulation, Drug: saline | Intervention Type: OTHER; Name: Electro-thermo-coagulation; Assigned to Arm(s): ETC + DAC N-055, ETC + physiological saline | Intervention Type: DRUG; Name: DAC N-055; Assigned to Arm(s): ETC + DAC N-055 | Intervention Type: DRUG; Name: saline; Assigned to Arm(s): ETC + physiological saline
D: Arm Label: IL SSG; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sodium Stibogluconate | Arm Label: ETC+MWT; Type: EXPERIMENTAL; Interventions: Procedure: Electro-thermo-coagulation, Drug: DAC N-055 | Arm Label: MWT; Type: EXPERIMENTAL; Interventions: Drug: DAC N-055 | Intervention Type: PROCEDURE; Name: Electro-thermo-coagulation; Assigned to Arm(s): ETC+MWT | Intervention Type: DRUG; Name: Sodium Stibogluconate; Assigned to Arm(s): IL SSG | Intervention Type: DRUG; Name: DAC N-055; Assigned to Arm(s): ETC+MWT, MWT

Answer: A